Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.

BACKGROUND MRI plays a crucial role to identify men with a high likelihood of clinically significant prostate cancer who require immediate biopsy. The added value of DCE MRI in combination with T2-weighted imaging and DWI is controversial (risks related to gadolinium administration, duration of MR exam, financial burden, effects on diagnostic performance). A comparison of a biparametric and a standard multiparametric MR imaging protocol, taking into account the different experience of the readers, may help to choose the best MR approach regarding diagnostic performance. PURPOSE To determine the added value of dynamic contrasted-enhanced imaging (DCE) over T2-weighted imaging (T2-WI) and diffusion weighted imaging (DWI) for the detection of clinically significant prostate cancer, and to evaluate how it affects the diagnostic performance of three readers with different grade of experience in prostate imaging. MATERIALS AND METHODS Eighty-five patients underwent prostate MR examination at 1.5 T MR scanner performed because of elevated prostate-specific antigen level and/or suspicion of prostate cancer at digital rectal examination. Two MR images sets (Set 1 = biparametric, Set 2 = multiparametric) were retrospectively and independently scored by three radiologists with 7, 3 and 1 years of experience in prostate MR imaging respectively, according to PI-RADS v2. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated by dichotomizing reader scores. Receiver operating characteristic (ROC) analysis was performed and areas under the curve (AUCs) were calculated for each reader and image set. A comparison of ROC curves was performed to test the difference between the areas under the ROC curves among the three readers. RESULTS There was no significant difference regarding the detection of clinically significant tumor among the three readers between the two image sets. The AUC for the bi-parametric and multi-parametric MR imaging protocol was respectively 0.68-0.72 (Reader 1), 0.72-0.70 (Reader 2) and 0.60-0.54 (Reader 3). ROC curve comparison revealed no statistically significant differences for each protocol among the most experienced (Reader 1) and the other readers (Readers 2-3). CONCLUSION The diagnostic accuracy of a bi-parametric MR imaging protocol consisting of T2-weighted imaging and DWI is comparable with that of a standard multi-parametric imaging protocol for the detection of clinically significant prostate cancer. The experience of the reader does not significantly modify the diagnostic performance of both MR protocols.

[1]  Arturo Brunetti,et al.  Biparametric 3T Magnetic Resonance Imaging for prostatic cancer detection in a biopsy-naïve patient population: a further improvement of PI-RADS v2? , 2016, European journal of radiology.

[2]  Beom Jin Park,et al.  Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI , 2012, European Radiology.

[3]  Nicola Schieda,et al.  False positive and false negative diagnoses of prostate cancer at multi-parametric prostate MRI in active surveillance , 2015, Insights into Imaging.

[4]  J. Fütterer,et al.  Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. , 2015, European urology.

[5]  B. Delahunt,et al.  The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System , 2015, The American journal of surgical pathology.

[6]  M. Roethke,et al.  Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance , 2015, Prostate Cancer and Prostatic Disease.

[7]  T. Sone,et al.  High b Value (2,000 s/mm2) Diffusion-Weighted Magnetic Resonance Imaging in Prostate Cancer at 3 Tesla: Comparison with 1,000 s/mm2 for Tumor Conspicuity and Discrimination of Aggressiveness , 2014, PloS one.

[8]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[9]  J. Kim,et al.  Is endorectal coil necessary for the staging of clinically localized prostate cancer? Comparison of non-endorectal versus endorectal MR imaging , 2010, World Journal of Urology.

[10]  S. Verma,et al.  Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. , 2011, AJR. American journal of roentgenology.

[11]  H. Rusinek,et al.  Whole‐lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy , 2015, Journal of magnetic resonance imaging : JMRI.

[12]  Michael Erb,et al.  Feasibility of accelerated simultaneous multislice diffusion‐weighted MRI of the prostate , 2017, Journal of magnetic resonance imaging : JMRI.

[13]  D. Margolis,et al.  PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. , 2016, European urology.

[14]  T. Scheenen,et al.  Multiparametric Magnetic Resonance Imaging in Prostate Cancer Management: Current Status and Future Perspectives , 2015, Investigative radiology.

[15]  J. Fütterer,et al.  Role of multiparametric magnetic resonance imaging in early detection of prostate cancer , 2016, Insights into Imaging.

[16]  Carlos Nicolau,et al.  Detection of Clinically Significant Prostate Cancer: Short Dual-Pulse Sequence versus Standard Multiparametric MR Imaging-A Multireader Study. , 2017, Radiology.

[17]  J. Fütterer,et al.  Pitfalls in Interpreting mp-MRI of the Prostate: A Pictorial Review with Pathologic Correlation , 2015, Insights into Imaging.

[18]  T. Sone,et al.  Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging. , 2011, AJR. American journal of roentgenology.

[19]  J. Babb,et al.  Length of capsular contact for diagnosing extraprostatic extension on prostate MRI: Assessment at an optimal threshold , 2016, Journal of magnetic resonance imaging : JMRI.

[20]  H. Shinmoto,et al.  Prostate cancer screening: The clinical value of diffusion‐weighted imaging and dynamic MR imaging in combination with T2‐weighted imaging , 2007, Journal of magnetic resonance imaging : JMRI.

[21]  H. Thomsen,et al.  Biparametric versus multiparametric MRI in the diagnosis of prostate cancer , 2016, Acta radiologica open.

[22]  P. Albers,et al.  MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy , 2014, European Radiology.

[23]  H. Hricak,et al.  Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference , 2016, European Radiology.

[24]  Simone Schrading,et al.  Abbreviated Biparametric Prostate MR Imaging in Men with Elevated Prostate-specific Antigen. , 2017, Radiology.